The product is usually injected subcutaneously (under the skin) or intramuscularly (into the muscle)
GLP-1 medication vials are subject to the 100 ml limit in carry-on bags in most jurisdictions
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 18 Long-Term Efficacy Trajectories of GLP-1 Receptor Agonists: A Systematic Review and Network Meta-Analysis Authors Li Z , Han Z, Sun R, Xuan X, Huang C Received 16 May 2025 Accepted for publication 19 August 2025 Published 23 September 2025 Volume 2025:18 Pages 36113624 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Halis Akturk Zixuan Li, 1, * Zhoubo Han, 1, * Rong Sun, 2 Xiuping Xuan, 3 Chenghu Huang 1 1 Department of Endocrinology, Bishan Hospital of Chongqing Medical University, Bishan, Chongqing, 402760, Peoples Republic of China
More approved uses may come
JAMA 324 (22), 22682280
Symptoms might include vomiting blood or passing black, tarry stools